Optegra continues expansion

Article

Optegra has acquired Memira's eye clinics in Munich and Stuttgart, Germany.

Optegra has acquired Memira's eye clinics in Munich and Stuttgart, Germany.

The move follows the firm's takeover of 23 of Lexum's European hospitals in the UK, Czech Republic, Germany and Poland. Optegra will continue to offer services in cataract, retinal, corneal, glaucoma and orbito-facial. Memira is a Scandinavian provider of refractive and intraocular eye surgery and will continue to expand in the Nordics.

Matthias Pertzsch, Optegra Germany Managing Director, noted, "This is an important step in our German expansion and we hope to continue to expand our national distribution further in 2013. We are actively looking for opportunities for partnership and acquisition of well-established, high-end existing ophthalmology practices."

"Combining the strength of professional medical competence with the structure, management expertise and marketing investment of Optegra will lead to lasting models of partnership between physicians and Optegra which ultimately benefit German patients."

For further details on Optegra clinics please click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.